{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cell apoptosis", "cell cycle arrest", "metastasis potency", "prostate cancer", "quinone analog"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31510010", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "10"}], "Language": ["eng"], "ELocationID": ["4459", "10.3390/ijms20184459"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "20", "Issue": "18", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "10"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability.", "Abstract": {"AbstractText": ["Prostate cancer (PCa), an epithelial malignant tumor, is the second common cause of cancer death among males in western countries. Thus, the development of new strategies is urgently needed. Tanshinones isolated from <i>Salvia miltiorrhiza</i> and its synthetic analogs show various biological activities including anticancer effects. Among them, the tanshinone analog 2-((Glycine methyl ester)methyl)-naphtho (<b>TC7</b>) is the most effective, with better selectivity and lower toxicity. Therefore, in this work, the effect of <b>TC7</b> against PCa was investigated through assessing the molecular mechanisms regulating the growth, metastasis, and invasion of PCa cells. Human PCa cells, PC3 and LNCAP, were used to evaluate <b>TC7</b> mechanisms of action in vitro, while male BALB/c nude mice were used for in vivo experiments by subjecting each mouse to a subcutaneous injection of PC3 cells into the right flank to evaluate <b>TC7</b> effects on tumor volume. Our in vitro results showed that <b>TC7</b> inhibited cell proliferation by arresting the cell cycle at G2/M through the regulation of cyclin b1, p53, GADD45A, PLK1, and CDC2/cyclin b1. In addition, <b>TC7</b> induced cell apoptosis by regulating apoptosis-associated genes such as p53, ERK1, BAX, p38, BCL-2, caspase-8, cleaved-caspase-8, PARP1, and the phosphorylation level of ERK1 and p38. Furthermore, it decreased DNA synthesis and inhibited the migration and invasion ability by regulating VEGF-1 and MMP-9 protein expression. Our in vivo evidence supports the conclusion that <b>TC7</b> could be considered as a potential promising chemotherapeutic candidate in the treatment of PCa."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of pharmacy, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Wang", "ForeName": "Mengling", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Zeng", "ForeName": "Xueyi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of pharmacy, Guizhou University, Guiyang 550025, China."}], "LastName": "Li", "ForeName": "Shengyou", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of pharmacy, Guizhou University, Guiyang 550025, China."}], "LastName": "Sun", "ForeName": "Zekun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": ["0000-0002-0378-0589"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Chen", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "College of pharmacy, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Shen", "ForeName": "Xiangchun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. panweidong@gzcnp.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China. panweidong@gzcnp.cn."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}, {"Identifier": ["0000-0003-3418-5739"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. luoheng@gzcnp.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China. luoheng@gzcnp.cn."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Abietanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Apoptosis Regulatory Proteins"}, {"RegistryNumber": "03UUH3J385", "NameOfSubstance": "tanshinone"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Abietanes"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Apoptosis Regulatory Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["metabolism", "pathology", "prevention & control"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Salvia miltiorrhiza"}, {"QualifierName": ["methods"], "DescriptorName": "Xenograft Model Antitumor Assays"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wang G., Zhao D., Spring D.J., Depinho R.A. Genetics and biology of prostate cancer. Genome Res. 2018;32:1105\u20131140. doi: 10.1101/gad.315739.118.", "ArticleIdList": ["10.1101/gad.315739.118", "PMC6120714", "30181359"]}, {"Citation": "Narayanan S., Srinivas S., Feldman D. Androgen\u2013glucocorticoid interactions in the era of novel prostate cancer therapy. Nat. Rev. Urol. 2015;13:47\u201360. doi: 10.1038/nrurol.2015.254.", "ArticleIdList": ["10.1038/nrurol.2015.254", "26643568"]}, {"Citation": "Castanares M.A., Copeland B.T., Chowdhury W.H., Liu M.M., Rodriguez R., Pomper M.G., Lupold S.E., Foss C.A. Characterization of a novel metastatic prostate cancer cell line of LNCaP origin. Prostate. 2016;76:215\u2013225. doi: 10.1002/pros.23115.", "ArticleIdList": ["10.1002/pros.23115", "PMC4729204", "26499105"]}, {"Citation": "Ishikura N., Kawata H., Nishimoto A., Nakamura R., Ishii N., Aoki Y. Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10. Prostate. 2010;70:457\u2013466. doi: 10.1002/pros.21079.", "ArticleIdList": ["10.1002/pros.21079", "19902465"]}, {"Citation": "Lee S.O., Dutt S.S., Nadiminty N., Pinder E., Liao H., Gao A.C. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Prostate. 2007;67:1293\u20131300. doi: 10.1002/pros.20621.", "ArticleIdList": ["10.1002/pros.20621", "17626246"]}, {"Citation": "Zhang S., Zheng C., Yao S., Wang Z., Xu L., Yang R., Meng X., Wu J., Zhou L., Sun Z. Proteomic analysis of human prostate cancer PC-3M-1E8 cells and PC-3M-2B4 cells of same origin but with different metastatic potential. PLoS ONE. 2018;13:e0206139. doi: 10.1371/journal.pone.0206139.", "ArticleIdList": ["10.1371/journal.pone.0206139", "PMC6209233", "30379883"]}, {"Citation": "Crawford E.D., Higano C.S., Shore N.D., Hussain M., Petrylak D.P. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies. J. Urol. 2015;194:1537\u20131547. doi: 10.1016/j.juro.2015.06.106.", "ArticleIdList": ["10.1016/j.juro.2015.06.106", "26196735"]}, {"Citation": "Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359\u2013E386. doi: 10.1002/ijc.29210.", "ArticleIdList": ["10.1002/ijc.29210", "25220842"]}, {"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA A Cancer J. Clin. 2019;69:7\u201334. doi: 10.3322/caac.21551.", "ArticleIdList": ["10.3322/caac.21551", "30620402"]}, {"Citation": "Zhu X., Albertsen P.C., Andriole G.L., Roobol M.J., Schroder F.H., Vickers A.J. Risk-based prostate cancer screening. Eur. Urol. 2012;61:652\u2013661. doi: 10.1016/j.eururo.2011.11.029.", "ArticleIdList": ["10.1016/j.eururo.2011.11.029", "PMC4716732", "22134009"]}, {"Citation": "Attard G., Parker C., Eeles R.A., Schroder F., Tomlins S.A., Tannock I., Drake C.G., de Bono J.S. Prostate cancer. Lancet (Lond. Engl.) 2016;387:70\u201382. doi: 10.1016/S0140-6736(14)61947-4.", "ArticleIdList": ["10.1016/S0140-6736(14)61947-4", "26074382"]}, {"Citation": "Wilt T.J., Brawer M.K., Jones K.M., Barry M.J., Aronson W.J., Fox S., Gingrich J.R., Wei J.T., Gilhooly P., Grob B.M., et al. Radical Prostatectomy versus Observation for Localized Prostate Cancer. N. Engl. J. Med. 2012;367:203\u2013213. doi: 10.1056/NEJMoa1113162.", "ArticleIdList": ["10.1056/NEJMoa1113162", "PMC3429335", "22808955"]}, {"Citation": "Mullins J.K., Feng Z., Trock B.J., Epstein J.I., Walsh P.C., Loeb S. The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary. J. Urol. 2012;188:2219\u20132224. doi: 10.1016/j.juro.2012.08.028.", "ArticleIdList": ["10.1016/j.juro.2012.08.028", "23083655"]}, {"Citation": "Kim C., Kim B. Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. Nutrients. 2018;10:1021. doi: 10.3390/nu10081021.", "ArticleIdList": ["10.3390/nu10081021", "PMC6115829", "30081573"]}, {"Citation": "David B., Wolfender J.-L., Dias D.A. The pharmaceutical industry and natural products: Historical status and new trends. Phytochem. Rev. 2014;14:299\u2013315. doi: 10.1007/s11101-014-9367-z.", "ArticleIdList": ["10.1007/s11101-014-9367-z"]}, {"Citation": "Bernardini S., Tiezzi A., Laghezza Masci V., Ovidi E. Natural products for human health: An historical overview of the drug discovery approaches. Nat. Prod. Res. 2018;32:1926\u20131950. doi: 10.1080/14786419.2017.1356838.", "ArticleIdList": ["10.1080/14786419.2017.1356838", "28748726"]}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Shakeri A., Cicero A.F.G., Panahi Y., Mohajeri M., Sahebkar A. Curcumin: A naturally occurring autophagy modulator. J. Cell Physiol. 2019;234:5643\u20135654. doi: 10.1002/jcp.27404.", "ArticleIdList": ["10.1002/jcp.27404", "30239005"]}, {"Citation": "Zou K., Li Z., Zhang Y., Zhang H.Y., Li B., Zhu W.L., Shi J.Y., Jia Q., Li Y.M. Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol. Sin. 2017;38:157\u2013167. doi: 10.1038/aps.2016.125.", "ArticleIdList": ["10.1038/aps.2016.125", "PMC5309756", "27917872"]}, {"Citation": "Millimouno F.M., Dong J., Yang L., Li J., Li X. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature. Cancer Prev. Res. 2014;7:1081\u20131107. doi: 10.1158/1940-6207.CAPR-14-0136.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0136", "25161295"]}, {"Citation": "Hur J.M., Shim J.S., Jung H.J., Kwon H.J. Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro. Exp. Mol. Med. 2005;37:133\u2013137. doi: 10.1038/emm.2005.18.", "ArticleIdList": ["10.1038/emm.2005.18", "15886527"]}, {"Citation": "Wei B., You M.G., Ling J.J., Wei L.L., Wang K., Li W.W., Chen T., Du Q.M., Ji H. Regulation of antioxidant system, lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats. Atherosclerosis. 2013;230:148\u2013156. doi: 10.1016/j.atherosclerosis.2013.07.005.", "ArticleIdList": ["10.1016/j.atherosclerosis.2013.07.005", "23958267"]}, {"Citation": "Zhou L., Zuo Z., Chow M.S.S. Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use. J. Clin. Pharmacol. 2005;45:1345\u20131359. doi: 10.1177/0091270005282630.", "ArticleIdList": ["10.1177/0091270005282630", "16291709"]}, {"Citation": "Fang J., Little P.J., Xu S. Atheroprotective Effects and Molecular Targets of Tanshinones Derived from Herbal Medicine Danshen. Med. Res. Rev. 2018;38:201\u2013228. doi: 10.1002/med.21438.", "ArticleIdList": ["10.1002/med.21438", "28295428"]}, {"Citation": "Xu D., Hu H., Guan J., Da J., Xie Y., Liu Y., Kong R., Song G., Zhou H. Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer. Chem. Biol. Drug Des. 2019 doi: 10.1111/cbdd.13567.", "ArticleIdList": ["10.1111/cbdd.13567", "31108007"]}, {"Citation": "Zhang Y., Guo S., Fang J., Peng B., Zhang Y., Cao T. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Exp. Ther. Med. 2018;16:2931\u20132937. doi: 10.3892/etm.2018.6562.", "ArticleIdList": ["10.3892/etm.2018.6562", "PMC6125958", "30214513"]}, {"Citation": "Wang P.Y., Hsu P.I., Wu D.C., Chen T.C., Jarman A.P., Powell L.M., Chen A. SUMOs Mediate the Nuclear Transfer of p38 and p-p38 during Helicobacter Pylori Infection. Int. J. Mol. Sci. 2018;19:2482. doi: 10.3390/ijms19092482.", "ArticleIdList": ["10.3390/ijms19092482", "PMC6163533", "30135361"]}, {"Citation": "Wu Y.J., Su T.R., Dai G.F., Su J.H., Liu C.I. Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway. Mar. Drugs. 2019;17:287. doi: 10.3390/md17050287.", "ArticleIdList": ["10.3390/md17050287", "PMC6562797", "31086026"]}, {"Citation": "Schonrogge M., Kerndl H., Zhang X., Kumstel S., Vollmar B., Zechner D. alpha-cyano-4-hydroxycinnamate impairs pancreatic cancer cells by stimulating the p38 signaling pathway. Cell. Signal. 2018;47:101\u2013108. doi: 10.1016/j.cellsig.2018.03.015.", "ArticleIdList": ["10.1016/j.cellsig.2018.03.015", "29609037"]}, {"Citation": "Chen S., Ren Z., Yu D., Ning B., Guo L. DNA damage-induced apoptosis and mitogen-activated protein kinase pathway contribute to the toxicity of dronedarone in hepatic cells. Environ. Mol. Mutagen. 2018;59:278\u2013289. doi: 10.1002/em.22173.", "ArticleIdList": ["10.1002/em.22173", "PMC7941192", "29399883"]}, {"Citation": "Sapkota G.P. The TGFbeta-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1. Open Biol. 2013;3:130067. doi: 10.1098/rsob.130067.", "ArticleIdList": ["10.1098/rsob.130067", "PMC3718330", "23760366"]}, {"Citation": "Bakin A.V., Rinehart C., Tomlinson A.K., Arteaga C.L. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 2002;115:3193\u20133206.", "ArticleIdList": ["12118074"]}, {"Citation": "Yu L., Hebert M.C., Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002;21:3749\u20133759. doi: 10.1093/emboj/cdf366.", "ArticleIdList": ["10.1093/emboj/cdf366", "PMC126112", "12110587"]}, {"Citation": "Aasrum M., Thoresen G.H., Christoffersen T., Brusevold I.J. p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines. J. Cell Commun. Signal. 2018;12:699\u2013707. doi: 10.1007/s12079-017-0444-0.", "ArticleIdList": ["10.1007/s12079-017-0444-0", "PMC6235781", "29380233"]}, {"Citation": "Vougiouklakis T., Sone K., Saloura V., Cho H.-S., Suzuki T., Dohmae N., Alachkar H., Nakamura Y., Hamamoto R. SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells. Oncotarget. 2015;6:43162\u201343171. doi: 10.18632/oncotarget.6351.", "ArticleIdList": ["10.18632/oncotarget.6351", "PMC4791223", "26586479"]}, {"Citation": "Cohen-Armon M., Visochek L., Rozensal D., Kalal A., Geistrikh I., Klein R., Bendetz-Nezer S., Yao Z., Seger R. DNA-Independent PARP-1 Activation by Phosphorylated ERK2 Increases Elk1 Activity: A Link to Histone Acetylation. Mol. Cell. 2007;25:297\u2013308. doi: 10.1016/j.molcel.2006.12.012.", "ArticleIdList": ["10.1016/j.molcel.2006.12.012", "17244536"]}, {"Citation": "Guo X.-X., Li Y., Sun C., Jiang D., Lin Y.-J., Jin F.-X., Lee S.-K., Jin Y.-H. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell. 2014;5:224\u2013234. doi: 10.1007/s13238-014-0027-2.", "ArticleIdList": ["10.1007/s13238-014-0027-2", "PMC3967063", "24622841"]}, {"Citation": "Ahn C.-H., Hong K.-O., Jin B., Lee W., Jung Y.C., Lee H., Shin J.-A., Cho S.-D., Hong S.D. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma. Int. J. Mol. Sci. 2019;20:3487. doi: 10.3390/ijms20143487.", "ArticleIdList": ["10.3390/ijms20143487", "PMC6678691", "31315217"]}, {"Citation": "Saggioro F.P., Neder L., St\u00e1vale J.N., Paix\u00e3o-Becker A.N.P., Malheiros S.M., Soares F.A., Pittella J.E.H., Matias C.C.M., Colli B.O., Carlotti C.G., et al. Fas, FasL, and cleaved caspases 8 and 3 in glioblastomas: A tissue microarray-based study. Pathol. Res. Pract. 2014;210:267\u2013273. doi: 10.1016/j.prp.2013.12.012.", "ArticleIdList": ["10.1016/j.prp.2013.12.012", "24561085"]}, {"Citation": "Sobhan P.K., Seervi M., Deb L., Varghese S., Soman A., Joseph J., Mathew K.A., Raghu G., Thomas G., E S., et al. Calpain and Reactive Oxygen Species Targets Bax for Mitochondrial Permeabilisation and Caspase Activation in Zerumbone Induced Apoptosis. PLoS ONE. 2013;8:e59350. doi: 10.1371/journal.pone.0059350.", "ArticleIdList": ["10.1371/journal.pone.0059350", "PMC3621898", "23593137"]}, {"Citation": "Bulavin D.V., Saito S., Hollander M.C., Sakaguchi K., Anderson C.W., Appella E., Fornace A.J. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999;18:6845\u20136854. doi: 10.1093/emboj/18.23.6845.", "ArticleIdList": ["10.1093/emboj/18.23.6845", "PMC1171747", "10581258"]}, {"Citation": "Zhu Y., Mao X.O., Sun Y., Xia Z., Greenberg D.A. p38 Mitogen-activated Protein Kinase Mediates Hypoxic Regulation of Mdm2 and p53 in Neurons. J. Biol. Chem. 2002;277:22909\u201322914. doi: 10.1074/jbc.M200042200.", "ArticleIdList": ["10.1074/jbc.M200042200", "11948180"]}, {"Citation": "H\u00e9ron-Milhavet L., Leroith D. Insulin-like Growth Factor I Induces MDM2-dependent Degradation of p53 via the p38 MAPK Pathway in Response to DNA Damage. J. Biol. Chem. 2002;277:15600\u201315606. doi: 10.1074/jbc.M111142200.", "ArticleIdList": ["10.1074/jbc.M111142200", "11877395"]}, {"Citation": "Alarcon-Vargas D., Ronai Z. p53-Mdm2--the affair that never ends. Carcinogenesis. 2002;23:541\u2013547. doi: 10.1093/carcin/23.4.541.", "ArticleIdList": ["10.1093/carcin/23.4.541", "11960904"]}, {"Citation": "Elias B., Laine A., Ronai Z. Phosphorylation of MdmX by CDK2/Cdc2p34 is required for nuclear export of Mdm2. Oncogene. 2005;24:2574\u20132579. doi: 10.1038/sj.onc.1208488.", "ArticleIdList": ["10.1038/sj.onc.1208488", "15735705"]}, {"Citation": "Park S.-H., Seong M.-A., Lee H.-Y. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells. Oncotarget. 2016;7:8184\u20138199. doi: 10.18632/oncotarget.6945.", "ArticleIdList": ["10.18632/oncotarget.6945", "PMC4884985", "26799187"]}, {"Citation": "Scott C.L., Swisher E.M., Kaufmann S.H. Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development. J. Clin. Oncol. 2015;33:1397\u20131406. doi: 10.1200/JCO.2014.58.8848.", "ArticleIdList": ["10.1200/JCO.2014.58.8848", "PMC4517072", "25779564"]}, {"Citation": "Bulavin D.V., Fornace A.J., Jr. p38 MAP kinase\u2019s emerging role as a tumor suppressor. Adv. Cancer Res. 2004;92:95\u2013118.", "ArticleIdList": ["15530558"]}, {"Citation": "Xu Y., Li N., Xiang R., Sun P. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem. Sci. 2014;39:268\u2013276. doi: 10.1016/j.tibs.2014.04.004.", "ArticleIdList": ["10.1016/j.tibs.2014.04.004", "PMC4358807", "24818748"]}, {"Citation": "Hou G., Chen B., Xu W., Zhao H., Liu K., Yao H. Expression level of CDC2 gene in osteosarcoma and its clinical significance. Oncol. Lett. 2018;15:7884\u20137888. doi: 10.3892/ol.2018.8307.", "ArticleIdList": ["10.3892/ol.2018.8307", "PMC5920721", "29731906"]}, {"Citation": "Chang C.-C., Hung C.-M., Yang Y.-R., Lee M.-J., Hsu Y.-C. Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J. Ovarian Res. 2013;6:41. doi: 10.1186/1757-2215-6-41.", "ArticleIdList": ["10.1186/1757-2215-6-41", "PMC3733945", "23799914"]}, {"Citation": "Ma Y.C., Su N., Shi X.J., Zhao W., Ke Y., Zi X., Zhao N.M., Qin Y.H., Zhao H.W., Liu H.M. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway. Toxicol. Appl. Pharmacol. 2015;282:227\u2013236. doi: 10.1016/j.taap.2014.11.003.", "ArticleIdList": ["10.1016/j.taap.2014.11.003", "PMC4721529", "25450480"]}, {"Citation": "Chen X., Liao Y., Long D., Yu T., Shen F., Lin X. The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro. Int. J. Mol. Med. 2017;40:235\u2013242. doi: 10.3892/ijmm.2017.2989.", "ArticleIdList": ["10.3892/ijmm.2017.2989", "28534969"]}, {"Citation": "Wu D., Chen K., Bai Y., Zhu X., Chen Z., Wang C., Zhao Y., Li M. Screening of diagnostic markers for osteosarcoma. Mol. Med. Rep. 2014;10:2415\u20132420. doi: 10.3892/mmr.2014.2546.", "ArticleIdList": ["10.3892/mmr.2014.2546", "25199469"]}, {"Citation": "Zhang B., Leng C., Wu C., Zhang Z., Dou L., Luo X., Zhang B., Chen X. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade. Oncol. Rep. 2016;35:1807\u20131815. doi: 10.3892/or.2015.4479.", "ArticleIdList": ["10.3892/or.2015.4479", "26647806"]}, {"Citation": "Moskalev A.A., Smit-McBride Z., Shaposhnikov M.V., Plyusnina E.N., Zhavoronkov A., Budovsky A., Tacutu R., Fraifeld V.E. Gadd45 proteins: Relevance to aging, longevity and age-related pathologies. Ageing Res. Rev. 2012;11:51\u201366. doi: 10.1016/j.arr.2011.09.003.", "ArticleIdList": ["10.1016/j.arr.2011.09.003", "PMC3765067", "21986581"]}, {"Citation": "Wingert S., Thalheimer F.B., Haetscher N., Rehage M., Schroeder T., Rieger M.A. DNA-damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival. Stem Cells (Dayt. Ohio) 2016;34:699\u2013710. doi: 10.1002/stem.2282.", "ArticleIdList": ["10.1002/stem.2282", "PMC4832267", "26731607"]}, {"Citation": "Smith L., Farzan R., Ali S., Buluwela L., Saurin A.T., Meek D.W. Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation. Sci. Rep. 2018;8:5237. doi: 10.1038/s41598-018-23384-5.", "ArticleIdList": ["10.1038/s41598-018-23384-5", "PMC5864844", "29568076"]}, {"Citation": "Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene. 2001;20:1803\u20131815. doi: 10.1038/sj.onc.1204252.", "ArticleIdList": ["10.1038/sj.onc.1204252", "11313928"]}, {"Citation": "Zachary I. Neuroprotective Role of Vascular Endothelial Growth Factor: Signalling Mechanisms, Biological Function, and Therapeutic Potential. Neurosignals. 2005;14:207\u2013221. doi: 10.1159/000088637.", "ArticleIdList": ["10.1159/000088637", "16301836"]}, {"Citation": "Peach C.J., Mignone V.W., Arruda M.A., Alcobia D.C., Hill S.J., Kilpatrick L.E., Woolard J. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. Int. J. Mol. Sci. 2018;19:1264. doi: 10.3390/ijms19041264.", "ArticleIdList": ["10.3390/ijms19041264", "PMC5979509", "29690653"]}, {"Citation": "Engsig M.T., Chen Q.-J., Vu T.H., Pedersen A.-C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones. J. Cell Biol. 2000;151:879\u2013890. doi: 10.1083/jcb.151.4.879.", "ArticleIdList": ["10.1083/jcb.151.4.879", "PMC2169432", "11076971"]}, {"Citation": "Kim Y.H., Kwon H.J., Kim D.S. Matrix metalloproteinase 9 (MMP-9)-dependent processing of betaig-h3 protein regulates cell migration, invasion, and adhesion. J. Biol. Chem. 2012;287:38957\u201338969. doi: 10.1074/jbc.M112.357863.", "ArticleIdList": ["10.1074/jbc.M112.357863", "PMC3493937", "23019342"]}, {"Citation": "Foxton R., Osborne A., Martin K.R., Ng Y.S., Shima D.T. Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism. Cell Death Dis. 2016;7:e2212. doi: 10.1038/cddis.2016.110.", "ArticleIdList": ["10.1038/cddis.2016.110", "PMC4917649", "27148685"]}, {"Citation": "Fang L.L., Sun B.F., Huang L.R., Yuan H.B., Zhang S., Chen J., Yu Z.J., Luo H. Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-beta Pathway. Int. J. Mol. Sci. 2017;18:2762. doi: 10.3390/ijms18122762.", "ArticleIdList": ["10.3390/ijms18122762", "PMC5751361", "29257105"]}, {"Citation": "Zhang Y.-Q., Wen Z.-H., Wan K., Yuan D., Zeng X., Liang G., Zhu J., Xu B., Luo H. A novel synthesized 3\u2032, 5\u2032-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways. Biomed. Pharmacother. 2018;106:794\u2013804. doi: 10.1016/j.biopha.2018.06.153.", "ArticleIdList": ["10.1016/j.biopha.2018.06.153", "29990873"]}, {"Citation": "Kongkathip N., Kongkathip B., Siripong P., Sangma C., Luangkamin S., Niyomdecha M., Pattanapa S., Piyaviriyagul S., Kongsaeree P. Potent antitumor activity of synthetic 1,2-Naphthoquinones and 1,4-Naphthoquinones. Bioorganic Med. Chem. 2003;11:3179\u20133191. doi: 10.1016/S0968-0896(03)00226-8.", "ArticleIdList": ["10.1016/S0968-0896(03)00226-8", "12818681"]}, {"Citation": "Li W., Liu J., Fu W., Zheng X., Ren L., Liu S., Wang J., Ji T., Du G. 3-O-acetyl-11-keto-beta-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. J. Exp. Clin. Cancer Res. CR. 2018;37:132. doi: 10.1186/s13046-018-0805-4.", "ArticleIdList": ["10.1186/s13046-018-0805-4", "PMC6029111", "29970196"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "31"}, {"Year": "2019", "Month": "8", "Day": "31"}, {"Year": "2019", "Month": "9", "Day": "3"}, {"Year": "2019", "Month": "9", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31510010", "PMC6770861", "10.3390/ijms20184459", "ijms20184459"]}}]}